Julie Appleby reports on the implementation of the health care overhaul law, the interplay of health care treatments and costs, trends in health insurance, and policy issues affecting hospitals and other medical providers. Her KHN stories have appeared in USA Today, the Washington Post, the Philadelphia Inquirer and MSNBC, among others. Before joining KHN in March 2009, Appleby spent 10 years on the health care industry and policy beat for USA Today. She also worked at the San Francisco Chronicle
, the Financial Times
in London and the Contra Costa Times
in Walnut Creek, Calif. She serves on the board of the Association of Health Care Journalists and her education includes a Master of Public Health degree. | Contact: JulieA@kff.org
Whether such programs spur long-term change is unclear, and some fear discrimination against those with chronic conditions.
KHN's Julie Appleby reports that the health law is so comprehensive that even if the Supreme Court struck the insurance requirement, many provisions would survive.
The long-awaited rules may disappoint consumer groups which had sought to reduce the clout of insurers on the governing boards.
Study finds that's mostly because the government pays far lower rates for hospital care – on average, $6,400 less than private plans do
While controversy over one aspect of the Obama administration's contraception rule – whether and when religiously affiliated employers must comply – has dominated recent headlines, that debate has obscured other questions about how the rules will actually be implemented.
Insurers switch to new way to calculate reimbursement that shifts more of the expenses onto patients.
Congress is betting more than $3 billion over the next decade that "comparative effectiveness" research can transform medical care by helping determine the best approach to a particular illness.
Technical, political and financial obstacles loom as clock ticks toward 2014 deadline for operations.
States will be given wide latitude to decide what “essential benefits” insurers must offer in policies offered on new health exchanges come 2014, the Obama administration said Friday in a move that pushes off final federal rules on those benefits until sometime next year.
Just as Walmart and other retailers shook up the pharmacy business by offering $4 generic drugs, the industry now aims to apply its clout to tackle unpredictable costs, a lack of primary care doctors and inefficient management of chronic illnesses.